{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:53:39Z","timestamp":1791428019031,"version":"4.3.3"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejca.2018.01.076","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T18:44:36Z","timestamp":1519238676000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"special_numbering":"C","title":["Blood classification and blood response criteria in mycosis fungoides\u00a0and S\u00e9zary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force"],"prefix":"10.1016","volume":"93","author":[{"given":"Julia J.","family":"Scarisbrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmilia","family":"Hodak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Stranzenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo L.","family":"Ortiz-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity","family":"Evison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Quaglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten H.","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2018.01.076_bib1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ejca.2018.01.076_bib2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood-2017-03-772996","article-title":"Circulating and skin-derived S\u00e9zary cells: clonal but with phenotypic plasticity","volume":"130","author":"Roelens","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2018.01.076_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","article-title":"The relevance of the CD4+CD26- subset in the identification of circulating Sezary cells","volume":"144","author":"Bernengo","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2018.01.076_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1067\/mjd.2002.118538","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: report of the international society for cutaneous lymphomas","volume":"46","author":"Vonderheid","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2018.01.076_bib5","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2018.01.076_bib6","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/bjd.12909","article-title":"Prognostic factors, prognostic indices and staging in mycosis fungoides and sezary syndrome: where are we now?","volume":"170","author":"Scarisbrick","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2018.01.076_bib7","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2018.01.076_bib8","first-page":"1","article-title":"Assessment of peripheral blood tumour burden in mycosis fungoides and s\u00e9zary syndrome shows infrequent involvement in early and tumour stage disease","volume":"1","author":"Yoo","year":"2015","journal-title":"J Immune Serum Biol"},{"issue":"5","key":"10.1016\/j.ejca.2018.01.076_bib9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2015.12.018","article-title":"Cutaneous T-cell lymphoma (CTCL): current practices in blood assessment and the utility of T-cell receptor (TCR)-V\u03b2 chain restriction","volume":"74","author":"Gibson","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2018.01.076_bib10","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ejca.2018.01.076_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0190-9622(96)90605-2","article-title":"Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses","volume":"35","author":"Harmon","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2018.01.076_bib12","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1002\/cncr.27627","article-title":"Time course, clinical pathways and long-term multicentre, retrospective follow-up study from the Italian Group of Cutaneous Lymphoma","volume":"118","author":"Quaglino","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2018.01.076_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10428194.2017.1334123","article-title":"CD4\u00b1CD26\u2212 lymphocytes are useful to assess blood involvement and define B ratings in cutaneous T cell lymphoma","volume":"59","author":"Vonderheid","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.ejca.2018.01.076_bib14","first-page":"e203","article-title":"A case of non-erythrodermic Sezary syndrome presenting with Hyperkeratosis of the Palms and Soles","volume":"35","author":"Iqbal","year":"2010","journal-title":"Clin Ex Dermatol"},{"key":"10.1016\/j.ejca.2018.01.076_bib15","first-page":"225","article-title":"Sezary syndrome \u2013 without erythroderma","volume":"68","author":"Abdul Samad","year":"2002","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"6","key":"10.1016\/j.ejca.2018.01.076_bib16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2014.11.015","article-title":"S\u00e9zary syndrome without erythroderma","volume":"72","author":"Henn","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ejca.2018.01.076_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaad.2016.10.029","article-title":"S\u00e9zary syndrome without erythroderma: a review of 16 cases at Mayo Clinic","volume":"76","author":"Thompson","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2018.01.076_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome\u2013 update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2018.01.076_bib19","first-page":"588","article-title":"The pre-Sezary erythroderma syndrome","volume":"49","author":"Winkelmann in 1974","year":"1974","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.ejca.2018.01.076_bib20","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0190-9622(84)80321-7","article-title":"Pre-S\u00e9zary syndrome","volume":"10","author":"Winkelmann","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2018.01.076_bib21","doi-asserted-by":"crossref","first-page":"317e320","DOI":"10.1038\/JID.2015.360","article-title":"Expression of s\u00e9zary biomarkers in the blood of erythrodermic mycosis fungoides patients","volume":"136","author":"Hurabielle","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"32","key":"10.1016\/j.ejca.2018.01.076_bib22","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous lymphoma international consortium (CLIC) study of outcome in advanced stages of mycosis fungoides & s\u00e9zary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick","year":"2015","journal-title":"J Clin Oncology"},{"issue":"13","key":"10.1016\/j.ejca.2018.01.076_bib23","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"Cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides & sezary syndrome","volume":"49","author":"Benton","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2018.01.076_bib24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.V97.3.624","article-title":"Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma","volume":"97","author":"Scarisbrick","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejca.2018.01.076_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-4632.2009.03771.x","article-title":"Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma","volume":"48","author":"Vidulich","year":"2009","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.ejca.2018.01.076_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP1NA3YCHCDEIG","article-title":"Blood flow cytometry in S\u00e9zary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-up","volume":"143","author":"Novelli","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.ejca.2018.01.076_bib27","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jid.2016.01.038","article-title":"Evaluation of immunophenotypic and molecular biomarkers for s\u00e9zary syndrome using standard operating procedures: a multicenter study of 59 patients","volume":"136","author":"Boonk","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"14","key":"10.1016\/j.ejca.2018.01.076_bib28","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1158\/1078-0432.CCR-16-3185","article-title":"Usefulness of KIR3DL2 to diagnose, follow-up, and manage the treatment of patients with S\u00e9zary syndrome","volume":"23","author":"Hurabielle","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2018.01.076_bib29","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918301102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918301102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T11:59:51Z","timestamp":1603886391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804918301102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":29,"alternative-id":["S0959804918301102"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.01.076","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood classification and blood response criteria in mycosis fungoides\u00a0and S\u00e9zary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.01.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}